Skip to main content
Top
Published in: Digestive Diseases and Sciences 1/2016

Open Access 01-01-2016 | Original Article

Frequent Use of Antibiotics Is Associated with Colorectal Cancer Risk: Results of a Nested Case–Control Study

Authors: Vincent K. Dik, Martijn G. H. van Oijen, Hugo M. Smeets, Peter D. Siersema

Published in: Digestive Diseases and Sciences | Issue 1/2016

Login to get access

Abstract

Background

Microbiotical dysbiosis induced by a Western diet seems to be associated with an increased risk of developing colorectal cancer (CRC). Few other factors with an effect on the colonic microbiota and their association with CRC have been evaluated.

Aim

We investigated whether the use of antibiotics is associated with CRC risk.

Methods

Data on the use of antibiotics and comedication were extracted from a health insurance database for subjects with a diagnostic-related group for CRC between 2006 and 2011 and four age- and sex-matched controls. Antibiotic use was categorized according to the number of prescriptions during a 5-year follow-up period (1–6 years prior to CRC). Multivariable conditional binary logistic regression analysis was used to estimate odds ratios (ORs) and 95 % confidence intervals (95 % CIs) for different levels of use.

Results

A total of 4029 cases (47 % male, mean age at diagnosis 71 ± 11 years) and 15,988 controls were included. Antibiotics had been prescribed to 2630 (65.3 %) cases and 10,234 (64.0 %) controls (p = 0.13). An increasing use of antibiotics was associated with an increasing risk of CRC [multivariable OR for high (≥8 prescriptions) vs. no prescriptions: 1.26, 95 % CI 1.11–1.44, p-trend <0.01]. For each increase of 5 prescriptions, the OR for CRC was 1.05 (95 % CI 1.01–1.09).

Conclusion

We found an association between the use of antibiotics, especially when used frequently, and the risk of developing CRC. Further studies are needed to establish under which conditions the use of antibiotics increases the risk of developing CRC.
Literature
1.
go back to reference Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–2917.CrossRefPubMed Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–2917.CrossRefPubMed
3.
go back to reference World Cancer Research Fund/American Institute for Cancer Research. Systematic Literature Review Continuous Update Project Report. 2011 (Ref Type: Internet Communication). World Cancer Research Fund/American Institute for Cancer Research. Systematic Literature Review Continuous Update Project Report. 2011 (Ref Type: Internet Communication).
4.
go back to reference Sommer F, Backhed F. The gut microbiota—masters of host development and physiology. Nat Rev Microbiol. 2013;11:227–238.CrossRefPubMed Sommer F, Backhed F. The gut microbiota—masters of host development and physiology. Nat Rev Microbiol. 2013;11:227–238.CrossRefPubMed
5.
go back to reference Augenlicht LH, Mariadason JM, Wilson A, et al. Short chain fatty acids and colon cancer. J Nutr. 2002;132:3804S–3808S.PubMed Augenlicht LH, Mariadason JM, Wilson A, et al. Short chain fatty acids and colon cancer. J Nutr. 2002;132:3804S–3808S.PubMed
7.
go back to reference Cox MA, Jackson J, Stanton M, et al. Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E(2) and cytokines. World J Gastroenterol. 2009;15:5549–5557.PubMedCentralCrossRefPubMed Cox MA, Jackson J, Stanton M, et al. Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E(2) and cytokines. World J Gastroenterol. 2009;15:5549–5557.PubMedCentralCrossRefPubMed
8.
go back to reference Davie JR. Inhibition of histone deacetylase activity by butyrate. J Nutr. 2003;133:2485S–2493S.PubMed Davie JR. Inhibition of histone deacetylase activity by butyrate. J Nutr. 2003;133:2485S–2493S.PubMed
9.
go back to reference Ebert MN, Klinder A, Peters WH, et al. Expression of glutathione S-transferases (GSTs) in human colon cells and inducibility of GSTM2 by butyrate. Carcinogenesis. 2003;24:1637–1644.CrossRefPubMed Ebert MN, Klinder A, Peters WH, et al. Expression of glutathione S-transferases (GSTs) in human colon cells and inducibility of GSTM2 by butyrate. Carcinogenesis. 2003;24:1637–1644.CrossRefPubMed
11.
go back to reference Kim YS, Milner JA. Dietary modulation of colon cancer risk. J Nutr. 2007;137:2576S–2579S.PubMed Kim YS, Milner JA. Dietary modulation of colon cancer risk. J Nutr. 2007;137:2576S–2579S.PubMed
13.
go back to reference Rodriguez-Cabezas ME, Galvez J, Lorente MD, et al. Dietary fiber down-regulates colonic tumor necrosis factor alpha and nitric oxide production in trinitrobenzenesulfonic acid-induced colitic rats. J Nutr. 2002;132:3263–3271.PubMed Rodriguez-Cabezas ME, Galvez J, Lorente MD, et al. Dietary fiber down-regulates colonic tumor necrosis factor alpha and nitric oxide production in trinitrobenzenesulfonic acid-induced colitic rats. J Nutr. 2002;132:3263–3271.PubMed
14.
go back to reference Waldecker M, Kautenburger T, Daumann H, et al. Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon. J Nutr Biochem. 2008;19:587–593.CrossRefPubMed Waldecker M, Kautenburger T, Daumann H, et al. Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon. J Nutr Biochem. 2008;19:587–593.CrossRefPubMed
15.
go back to reference Ou J, Carbonero F, Zoetendal EG, et al. Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. Am J Clin Nutr. 2013;98:111–120.PubMedCentralCrossRefPubMed Ou J, Carbonero F, Zoetendal EG, et al. Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. Am J Clin Nutr. 2013;98:111–120.PubMedCentralCrossRefPubMed
16.
go back to reference Vipperla K, O’Keefe SJ. The microbiota and its metabolites in colonic mucosal health and cancer risk. Nutr Clin Pract. 2012;27:624–635.CrossRefPubMed Vipperla K, O’Keefe SJ. The microbiota and its metabolites in colonic mucosal health and cancer risk. Nutr Clin Pract. 2012;27:624–635.CrossRefPubMed
17.
go back to reference Wells JE, Hylemon PB. Identification and characterization of a bile acid 7alpha-dehydroxylation operon in Clostridium sp. strain TO-931, a highly active 7alpha-dehydroxylating strain isolated from human feces. Appl Environ Microbiol. 2000;66:1107–1113.PubMedCentralCrossRefPubMed Wells JE, Hylemon PB. Identification and characterization of a bile acid 7alpha-dehydroxylation operon in Clostridium sp. strain TO-931, a highly active 7alpha-dehydroxylating strain isolated from human feces. Appl Environ Microbiol. 2000;66:1107–1113.PubMedCentralCrossRefPubMed
18.
go back to reference Ou J, Delany JP, Zhang M, et al. Association between low colonic short-chain fatty acids and high bile acids in high colon cancer risk populations. Nutr Cancer. 2012;64:34–40.CrossRefPubMed Ou J, Delany JP, Zhang M, et al. Association between low colonic short-chain fatty acids and high bile acids in high colon cancer risk populations. Nutr Cancer. 2012;64:34–40.CrossRefPubMed
20.
go back to reference Balamurugan R, Rajendiran E, George S, et al. Real-time polymerase chain reaction quantification of specific butyrate-producing bacteria, Desulfovibrio and Enterococcus faecalis in the feces of patients with colorectal cancer. J Gastroenterol Hepatol. 2008;23:1298–1303.CrossRefPubMed Balamurugan R, Rajendiran E, George S, et al. Real-time polymerase chain reaction quantification of specific butyrate-producing bacteria, Desulfovibrio and Enterococcus faecalis in the feces of patients with colorectal cancer. J Gastroenterol Hepatol. 2008;23:1298–1303.CrossRefPubMed
22.
go back to reference Smeets HM, de Wit NJ, Hoes AW. Routine health insurance data for scientific research: potential and limitations of the Agis Health Database. J Clin Epidemiol. 2011;64:424–430.CrossRefPubMed Smeets HM, de Wit NJ, Hoes AW. Routine health insurance data for scientific research: potential and limitations of the Agis Health Database. J Clin Epidemiol. 2011;64:424–430.CrossRefPubMed
24.
go back to reference Dutch National Guideline for Colon Cancer. CBO; 2008. Dutch National Guideline for Colon Cancer. CBO; 2008.
25.
go back to reference Dutch National Guideline for Rectal Cancer. CBO; 2008. Dutch National Guideline for Rectal Cancer. CBO; 2008.
26.
go back to reference Kilkkinen A, Rissanen H, Klaukka T, et al. Antibiotic use predicts an increased risk of cancer. Int J Cancer. 2008;123:2152–2155.CrossRefPubMed Kilkkinen A, Rissanen H, Klaukka T, et al. Antibiotic use predicts an increased risk of cancer. Int J Cancer. 2008;123:2152–2155.CrossRefPubMed
27.
go back to reference Candela M, Turroni S, Biagi E, et al. Inflammation and colorectal cancer, when microbiota-host mutualism breaks. World J Gastroenterol. 2014;20:908–922.PubMedCentralCrossRefPubMed Candela M, Turroni S, Biagi E, et al. Inflammation and colorectal cancer, when microbiota-host mutualism breaks. World J Gastroenterol. 2014;20:908–922.PubMedCentralCrossRefPubMed
28.
go back to reference Wang JL, Chang CH, Lin JW, et al. Infection, antibiotic therapy and risk of colorectal cancer: a nationwide nested case-control study in patients with Type 2 diabetes mellitus. Int J Cancer. 2014;135:956–967.CrossRefPubMed Wang JL, Chang CH, Lin JW, et al. Infection, antibiotic therapy and risk of colorectal cancer: a nationwide nested case-control study in patients with Type 2 diabetes mellitus. Int J Cancer. 2014;135:956–967.CrossRefPubMed
29.
go back to reference Snyder RD. An update on the genotoxicity and carcinogenicity of marketed pharmaceuticals with reference to in silico predictivity. Environ Mol Mutagen. 2009;50:435–450.CrossRefPubMed Snyder RD. An update on the genotoxicity and carcinogenicity of marketed pharmaceuticals with reference to in silico predictivity. Environ Mol Mutagen. 2009;50:435–450.CrossRefPubMed
30.
go back to reference Attur MG, Patel RN, Patel PD, et al. Tetracycline up-regulates COX-2 expression and prostaglandin E2 production independent of its effect on nitric oxide. J Immunol. 1999;162:3160–3167.PubMed Attur MG, Patel RN, Patel PD, et al. Tetracycline up-regulates COX-2 expression and prostaglandin E2 production independent of its effect on nitric oxide. J Immunol. 1999;162:3160–3167.PubMed
31.
32.
go back to reference Didham RC, Reith DM, McConnell DW, et al. Antibiotic exposure and breast cancer in New Zealand. Breast Cancer Res Treat. 2005;92:163–167.CrossRefPubMed Didham RC, Reith DM, McConnell DW, et al. Antibiotic exposure and breast cancer in New Zealand. Breast Cancer Res Treat. 2005;92:163–167.CrossRefPubMed
33.
go back to reference Kato I, Koenig KL, Baptiste MS, et al. History of antibiotic use and risk of non-Hodgkin’s lymphoma (NHL). Int J Cancer. 2003;107:99–105.CrossRefPubMed Kato I, Koenig KL, Baptiste MS, et al. History of antibiotic use and risk of non-Hodgkin’s lymphoma (NHL). Int J Cancer. 2003;107:99–105.CrossRefPubMed
34.
go back to reference Tamim HM, Hajeer AH, Boivin JF, et al. Association between antibiotic use and risk of prostate cancer. Int J Cancer. 2010;127:952–960.PubMed Tamim HM, Hajeer AH, Boivin JF, et al. Association between antibiotic use and risk of prostate cancer. Int J Cancer. 2010;127:952–960.PubMed
35.
go back to reference Velicer CM, Heckbert SR, Lampe JW, et al. Antibiotic use in relation to the risk of breast cancer. JAMA. 2004;291:827–835.CrossRefPubMed Velicer CM, Heckbert SR, Lampe JW, et al. Antibiotic use in relation to the risk of breast cancer. JAMA. 2004;291:827–835.CrossRefPubMed
36.
go back to reference Zhang H, Garcia Rodriguez LA, Hernandez-Diaz S. Antibiotic use and the risk of lung cancer. Cancer Epidemiol Biomarkers Prev. 2008;17:1308–1315.CrossRefPubMed Zhang H, Garcia Rodriguez LA, Hernandez-Diaz S. Antibiotic use and the risk of lung cancer. Cancer Epidemiol Biomarkers Prev. 2008;17:1308–1315.CrossRefPubMed
37.
Metadata
Title
Frequent Use of Antibiotics Is Associated with Colorectal Cancer Risk: Results of a Nested Case–Control Study
Authors
Vincent K. Dik
Martijn G. H. van Oijen
Hugo M. Smeets
Peter D. Siersema
Publication date
01-01-2016
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2016
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-015-3828-0

Other articles of this Issue 1/2016

Digestive Diseases and Sciences 1/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.